Evolve Biosystems, Inc.   Report issue

For profit Phase 1
Founded: Davis CA United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2014
NCT02457338
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Evolve BioSystems | Evolve BioSystems, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

bifidobacterium animalis (2 trials)

Drugs in Other Trials (3)

bifidobacterium infantis (5 trials)

lacto-n-tetraose (1 trial)

lactose (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 7
  • # of Trial APIs: 4